ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Respiratory Tract Diseases
Rhinitis
Chronic Obstructive Pulmonary Disease
Dust Mite Allergy
Lung Diseases

Asthma trials near Hanyang, Seoul, KOR:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Seoul, South Korea and 111 other locations

The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...

Active, not recruiting
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)

Phase 2

Upstream Bio

Seoul, South Korea and 157 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Seoul, South Korea and 335 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Seoul, South Korea and 141 other locations

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....

Active, not recruiting
Asthma
Drug: Placebo
Drug: Rocatinlimab

Phase 2

Amgen
Amgen

Seoul, South Korea and 154 other locations

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Enrolling
Severe Asthma
Drug: Verekitug
Drug: Placebo

Phase 2

Upstream Bio

Seoul, South Korea, South Korea and 83 other locations

This is a study of amlitelimab for the treatment of participants with moderate-to-severe asthma. The study will have a double-blind treatmen...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Amlitelimab

Phase 2

Sanofi
Sanofi

Seoul, Seoul-teukbyeolsi, South Korea and 67 other locations

trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...

Active, not recruiting
Asthma
Drug: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
Drug: Inhaled corticosteroids/long-acting beta-2 agonists

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Seoul, South Korea and 73 other locations

PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Seoul, Seoul-teukbyeolsi [seoul], South Korea and 124 other locations

This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma ...

Enrolling
Asthma
Drug: Lunsekimig

Phase 2

Sanofi
Sanofi

Seoul, Seoul-teukbyeolsi, South Korea and 116 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems